【资料】美国的CME学习病例_A 47-Year-Old Woman With Urinary Incontinence
Course Objectives
After successfully completing this course, participants should be able to
define overactive bladder (OAB) syndrome, urgency, frequency, and nocturia (International Continence Society definitions);
understand the prevalence of OAB and the syndrome’s impact on quality of life;
evaluate patients with symptoms of OAB and discuss treatment options;
educate patients regarding behavioral and medical therapies available for OAB symptoms; and
know when it is appropriate to refer patients to a specialist for further evaluation.
Disclosure Information
The authors and editors have disclosed the following commercial relationships or affiliations that could be perceived as real or apparent conflicts of interest.
Case Author(s) Disclosure
Matthew P. Rutman, MD
Assistant Professor of Urology
Co-Director of Voiding Dysfunction and Female Urology
Department of Urology
Columbia University College of Physicians and Surgeons Sources of Funding for Research: None
Consulting Agreements: None
Speakers Bureau/Honorarium Agreements: None
Financial Interests/Stock Ownership: None
Discussion of Off-label, Investigational, or Experimental Drug Use: None
Case Editor(s) Disclosure
Jason P. Gilleran, MD
Assistant Professor
Division of Urology
Ohio State University Medical Center
Columbus, Ohio Sources of Funding for Research: None
Consulting Agreements: None
Speakers Bureau/Honorarium Agreements: None
Financial Interests/Stock Ownership: None
Discussion of Off-label, Investigational, or Experimental Drug Use: None
Target Audience
Physicians (MD, DO, or equivalent)
Estimated Completion Time
1 hour
Original Publication Date
July 20, 2006
Submission Deadline Date
July 20, 2007
Instructions to Participants
The course structure is based on a case presentation system. Please click, review, and/or complete items on each screen, left to right, starting with Introductory Information on the top left side of the module and ending with Total Score, which is the last tab on the right. Your answers will be recorded during the course. A score of 70% is required to pass. Once you have obtained the passing score, a login/registration box will appear. After you log in (returning eMedicine users) or register (new eMedicine users), you must complete a short course survey/evaluation to obtain your continuing medical education certificate. You may immediately view and print your certificate, and a copy will also be emailed to the address you provided upon registration.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Nebraska Medical Center, Center for Continuing Education and eMedicine. The University of Nebraska Medical Center, Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclaimer
Medicine is a constantly changing science, and clearly established therapies are not always available for every condition. New research findings necessitate continual changes in drug and treatment therapies. Reasonable efforts have been made to provide up-to-date, accurate information that is within generally accepted medical standards at the time of publication. However, as medical science is ever evolving, and human error is always possible, the provider, commercial supporter(s), and publisher (or any other involved party) do not guarantee total accuracy or comprehensiveness of the information in this article, and they are not responsible for omissions or errors or the results of using information provided in this course. Participants should confirm the accuracy of the information in this activity from other sources. In particular, all drug doses, indications, and contraindications should be confirmed in package inserts.